Prostratin, PKC activator
Prostratin, PKC activator Basic information
- Product Name:
- Prostratin, PKC activator
- Synonyms:
-
- SA 101A
- Prostatin >99%
- 12-Deoxyphorbol 13-Acetate, dPAc
- (1aR,1bS,4aR,7aS,7bR,8R,9aS)-9a-(Acetyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a -decahydro-4a,7b-dihydroxy-3-(hydroxyMethyl)-1,1,6,8-tetraMethyl-
- 13-O-Acetyl-12-deoxyphorbol
- PROSTRATIN
- (1aR,1bS,4aR,7aS,7bR,8R,9aS)-9a-(Acetyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a -decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl- 5H-cyclopropa[3,4]benz[1,2-e]azulen-5-one
- 13-O-Acetylphorbol
- CAS:
- 60857-08-1
- MF:
- C22H30O6
- MW:
- 390.47
- Product Categories:
-
- Activator
- Chiral Reagents
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Protein Kinase Inhibitors and Activators
- Mol File:
- 60857-08-1.mol
Prostratin, PKC activator Chemical Properties
- Melting point:
- 216-219℃
- Boiling point:
- 550.5±50.0 °C(Predicted)
- Density
- 1.31
- storage temp.
- -20°C
- solubility
- Soluble in DMSO at 30mg/ml
- form
- white powder
- pka
- 11.40±0.70(Predicted)
- color
- Off-white
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
Prostratin, PKC activator Usage And Synthesis
Description
Activation of latent reservoirs of HIV-
Uses
Activation of latent reservoirs of HIV-infected cells is a treatment strategy designed to reduce viral load and eliminate the perpetuation of retroviral infection. Prostratin is a non-tumor promoting phorbol ester that potently induces HIV-1 reactivation in latent reservoirs of infected Jurkat-LAT-GFP cells . [Cayman Chemical]
Definition
ChEBI: A natural product found in Euphorbia fischeriana.
Biochem/physiol Actions
Prostratin, an unusual non-tumorigenic phorbol ester, is an activator of protein kinase C (PKC) and also an activator of nuclear factor KB (NF-KB) mediated through activation of the IKKs (IKB kinases). Prostratin exhibits potent in vitro activity by inducing HIV expression in latently infected cell lines and primary cells, thus antagonizing HIV latency. Activation of PKC and NF-kB has been proposed as the mechanism of action. Prostratin also inhibits HIV entry into target cells by down-regulating CD4 and CXCR4 receptors.
References
1) Cashmore et al. (1976), The structure of prostratin: a toxic tetracyclic diterpene ester from Pimelea Prostrata; Tetrahedron Lett., 17 1737 2) Miana et al. (2015), Prostratin: An Overview; Mini Rev. Med. Chem., 15 1122 3) Shen et al. (2015), The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents; Cancer Lett., 356 (2 Pt. B) 686 4) Biancotto et al. (2004), Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue; J. Virol., 78 10507 5) Geribaldi-Doldan et al. (2015), 12-Deoxyphorbols Promote Adult Neurogenesis by Inducing Neural Progenitor Cell Proliferation via PKC activation ; Int. J, Neuropsychopharmacol., 19 pyv085
Prostratin, PKC activatorSupplier
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 021-50790412
- info@chemvon.com
- Tel
- 025-83697070
- info@chemlin.com.cn
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 021-61551611 13296011611
- contact@trustwe.com
Prostratin, PKC activator(60857-08-1)Related Product Information
- PHORBOL 12-MYRISTATE 13-ACETATE
- Prostratin, PKC activator
- NS-398
- H-ARG-ARG-LEU-ILE-GLU-ASP-ASN-GLU-TYR-THR-ALA-ARG-GLY-OH
- PHORBOL 12,13-DIBUTYRATE
- 3H-PMA
- PHORBOL 12,13-DIACETATE
- PHORBOL 12,13-DIDECANOATE
- PHORBOL 13-ACETATE
- PHORBOL-12,13-DIHEXANOATE
- PHORBOL 12,13,20-TRIACETATE, 4BETA
- PHORBOL 12-MYRISTATE 13-ACETATE 4-O-METHYL ETHER, 4BETA
- PHORBOL 12-N-METHYLANTHRANILATE
- PHORBOL 16-HYDROXY 12-PALMITATE 13-ACETATE
- 3H-PDBU
- 3H-PDA
- PHORBOL 13,20-DIACETATE
- PHORBOL-13-DECANOATE